CLINICAL_TRIALS
trial_result
· 2015-04-03
Clinical Trial Update: Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children [Phase 2]
Summary
A Phase 2 dose-ranging trial of vilanterol inhalation powder for asthma in children has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2015-04-03